Pharmacy Podcast Network

Uncovering The First Year of Medical School with Dr. Tim Do | The Physician Pharmacist Podcast

Have you ever considered a career in medicine after pharmacy? Join us today to explore what the first year of medical school is like and how it compares to pharmacy! In today’s show, we will cover topics related to application logistics, basic MCAT principles, application timing, applying to pharmacy residencies, tackling pharmacy boards, adjusting to the medical school life, and reflections on a career in medicine!
Links:
1. Medical School Application Platform; AMCAS - https://students-residents.aamc.org/
2. American Association of Colleges of Osteopathic Medicine (AACOM): - https://www.aacom.org/
3. Medical School Acceptance Rates By Major in 2022 (BeMo) - https://bemoacademicconsulting.com/blog/medical-school-acceptance-rates-by-major
Learn more about your ad choices. Visit megaphone.fm/adchoices

Congressman Buddy Carter and General Counsel of NCPA Matthew Seiler on PBM Reform

Congressman Buddy Carter and General Counsel of NCPA Matthew Seiler on PBM Reform. On this episode of the 'PBM Reform Podcast' we discuss the Pharmacy Benefit Manager (PBM) Transparency Act of 2022 (the Act) was recently proposed in the U.S. Senate and intends to incentivize “fair and transparent” PBM practices, prohibit spread pricing and claw backs of payments to pharmacies, and empower the Federal Trade Commission (FTC) and state attorneys general in enforcement actions to stop “unfair and deceptive” PBM business practices.
The Act was introduced by Senators Maria Cantwell Chuck Grassley on May 24, 2022, and was approved by the Commerce Committee with bipartisan support (19-9) on June 22, 2022. This summary provides a high-level overview of the Act’s key measures.
Prohibition on Unfair or Deceptive Prescription Drug Pricing Practices
The Act would make it illegal for PBMs to:
Engage in “spread pricing,” which is described as charging a health plan or payer a different amount for a prescription drug’s ingredient cost or dispensing fee than the amount the PBM reimburses a pharmacy for the prescription drug’s ingredient cost or dispensing fee where the PBM retains the amount of any such difference;
Arbitrarily, unfairly, or deceptively reduce or rescind (a.k.a. “claw back”) any portion of the reimbursement payment to a pharmacist or pharmacy for a prescription drug’s ingredient cost of dispensing fee; or
Arbitrarily, unfairly, or deceptively increase or lower fees and reimbursements to a pharmacy to offset reimbursement changes under any federally funded health plan.
The Act would incentivize transparency by stating that a PBM shall not be in violation of the Act if the PBM passes through 100% of price concessions to a health plan or payer and provides complete disclosure of:
The cost, price, and reimbursement of prescription drugs to each health plan, payer, and pharmacy;
All fees, markups, and discounts the PBM charges or imposes on each health plan, payer, and pharmacy; and
The aggregate remuneration PBM receives from drug manufacturers, including nay rebate, discount, administration fee, and any other payment or credit obtained or retained by PBM.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacists Leading in Public Health | Pharmacy Podcast Nation

Dr. Jennifer N. Lind, PharmD, MPH, MBA
Jennifer N. Lind, PharmD, MPH, MBA, is a Pharmacist and Epidemiologist in CDC’s Medication Safety Program and a Commander in the United States Public Health Service Commissioned Corps. CDR Lind received her Doctor of Pharmacy degree from Florida A&M University in 2007, Master of Public Health from Georgia State University in 2012, and Master of Business Administration from Emory University in May 2022. After receiving her MPH, she completed a two-year fellowship as an Epidemic Intelligence Service (EIS) officer in CDC’s National Center for Chronic Disease Prevention and Health Promotion, conducting research and surveillance related to infant and young child feeding practices. 
Following EIS, she worked in CDC’s Birth Defects Branch and eventually became the Lead Scientist for CDC’s Treating for Two initiative, focused on safer medication use in pregnancy. CDR Lind’s current work in CDC’s Medication Safety Program focuses on reducing harms from the use of medications and she serves as Lead Pharmacist for the PROTECT initiative, an innovative public-private partnership that uses a collaborative, data-driven approach to reduce harms from unintentional medication overdoses in children. CDR Lind has also been a leader in multiple emergency responses, including COVID-19.
 
During her 15 years of experience, CDR Lind has authored/co-authored 35 publications, presented at national and international conferences, and has been interviewed/featured by numerous media outlets, including the national radio show “Top of Mind with Julie Rose,” USA Today, Consumer Reports, CNN, The Doctors Channel, and HealthDay News.
For more information regarding CDC’s Medication Safety Program, the PRevention of Overdoses and Treatment Errors in Children Taskforce (PROTECT) Initiative, and Up & Away, please visit: www.cdc.gov/medicationsafety  
For the most up-to-date information regarding COVID-19 vaccination, please visit: www.cdc.gov/vaccines/covid-19
To learn more about the United States Public Health Service Commissioned Corps, please visit: www.usphs.gov
To learn more about the Epidemic Intelligence Service (EIS) program, please visit: www.cdc.gov/eis  
Learn more about your ad choices. Visit megaphone.fm/adchoices

I Don’t Lichen It, I Love It! | Holistic Journal Club with Susan Egbert | Holistic Pharmacy Podcast

Join host Jenna Carmichael, PharmD for a discussion on Antimycobacterial activity of acetone extract and isolated metabolites from folklore medicinal lichen Usnea laevis Nyl. against drug-sensitive and multidrug-resistant tuberculosis strains with guest Susan Egbert, PharmD. 
Susan (she/her) completed her PharmD at the University of Louisiana at Monroe (ULM). During school, she realized that there's still not a lot done on natural products despite a fair number of drugs having natural origins. Currently, Susan is a third year PhD candidate in chemistry at the University of Manitoba (U of M). Her research is focusing on lichens, biosynthesis of their secondary metabolites, and their pharmacological activity.
Article link: https://pubmed.ncbi.nlm.nih.gov/34536516/ 
How to get in touch with Susan:
Email: sbegbert80@gmail.com 
Twitter: @lichenlady94
Instagram: @lichenlady94
Dr. Jenna Carmichael of Wobbly Arrow Wellness is a holistic oncology pharmacist and health coach. She works with women on the cancer journey looking for a different perspective on wellness. She combines her knowledge in the oncology space along with holistic healing methods of meditation, reiki, and yoga to help empower her clients to choose the path that works the best for their goals. She also offers genetic testing services to get a true, personalized idea of how her clients process their medications for safe and effective therapy. Go to www.wobblyarrowwellness.com for more information on her services.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Navigating the Patient Journey in Specialty Pharmacy- From Evaluation Through Treatment | NASP

Podcast Participants: Mike Baldzicki (AscellaHealth), Randy Falkenrath (President, Onco360), Justin Manning, PharmD (Group Vice President, Business Development, Vivid Clear Rx)
Summary: The specialty pharmacy patient journey is a process, and it starts at the point of care with patient and prescriber, and it goes all the way through the treatment of therapy. Specialty Pharmacy is defined as the service created to manage the handling and service requirements of specialty pharmaceuticals, including dispensing, distribution, reimbursement, case-management and other services specific to patients with rare and/or chronic diseases. There are a lot of extra steps in dispensing a specialty medication, so there's a lot of work to be done by pharmacists and care coordination teams before the specialty drug is given to the patient. Obviously, there’s a higher cost, and so it takes more personnel and systems, so there is more patient coordination needed prior to the pharmacy to dispense that specialty medication. The value of the specialty pharmacist in helping patients to access treatment, adhere to treatment, and really get the best possible outcome of treatment really cannot be overstressed as specialty pharmacist are often responsible for selecting the most appropriate therapy based on the patient's clinical and financial profile or reviewing that prescribed medication to ensure access for the patient. The Specialty Pharmacy Care Teams provide significant mentoring to patients to ensure not only safety but also effectiveness and being proactive and changing therapy so that patients are really getting the best possible benefit or changing to a different medication that may give them a better effect. The specialty pharmacists are an anchor during therapy that they can rely on to make sure that they are helping them deal with complex, challenging, and sometimes lifelong therapies as the specialty care teams play an important role in the patient care journey.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Continuing the Conversation | Optimizing Care for Patients With Endometrial Cancer: A Focus on Pharmacist Interventions and Mitigation of Health Equit...

·      Recognize the role of biomarker expression in the selection of most appropriate treatment options for patients with endometrial cancer
·      Review strategies for identification and management of drug-related toxicities in patients receiving therapy with immune checkpoint inhibitors, targeted agents, or combination therapy
Faculty:
Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist, Gynecologic Oncology
Stephenson Cancer Center at OU Health
University of Oklahoma Health Science Center
Oklahoma City, Oklahoma
Sarah Hayward, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Consultant (advisory board): GSK, Seagen/Genmab
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-322-H01-P. The activity is available for CE credit through June 30, 2023.
This educational activity is supported by an educational grant from GlaxoSmithKline
Learn more about your ad choices. Visit megaphone.fm/adchoices

Understanding Chronic Lymphocytic Leukemia Drug Therapies | PTCE Pharmacy Connect

The use of oral therapies for chronic lymphocytic leukemia has had a great impact on patient outcomes and quality of life. Pharmacists can play a key role in assisting with therapy selection, education for patients and the healthcare team, and also managing adverse effects for patients receiving these therapies.
Objectives
Differentiate novel therapies for the treatment of chronic lymphocytic leukemia (CLL) by pharmacologic properties and special considerations for use
Associate drug therapy and safety and efficacy information with treatment selection for patients with CLL
Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.
Dr. Tobon has no relevant financial relationships with commercial interests to disclose.
Accreditation and support statement: 
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Role of JAK Inhibitors in the Management of Atopic Dermatitis

This podcast will specifically focus on clinical safety and efficacy data supporting the use of new and emerging JAK inhibitors in the management of AD. Practical counseling points for pharmacists to provide individualized care and proper selection of therapy to patients with AD who are initiating therapy with JAK inhibitors will also be discussed. Faculty experts will review audience questions and identify best practices in the management of AD.
o  The Role of JAK Inhibitors in the Management of Atopic Dermatitis: Latest Advances and Best Practices for the Pharmacist
o  Introduction of faculty, affiliations, and disclosures
We would like to thank Sarah Lant, PharmD for her contribution in developing the content for this podcast.
Lana Gerzenshtein, PharmD and Sarah Lant have no relevant financial relationships with commercial interests to disclose.
o  Accreditation and support statement
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
This activity is supported by educational grants from Incyte.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Chronic Lymphocytic Leukemia: Insights into the Pharmacist Role in Therapy Management | PTCE Pharmacy Connect

Introduction of faculty and disclosures: 
Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.
Dr. Tobon has no relevant financial relationships with commercial interests to disclose.
Accreditation and support statement: 
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Integrating CGM into Diabetes Education | Beyond the Sig

Join us today as we talk all things continuous glucose monitoring with a diabetes care and education specialist, Dr. Diana Isaacs. Learn more about the barriers and challenges associated with using CGM for your patients and strategies to overcome these challenges. In addition, Dr. Diana Isaacs walks us through the newest technologies and innovations in the diabetes management space as diabetes care has transformed drastically in the last decade.  
Learn more about your ad choices. Visit megaphone.fm/adchoices

Advocating for Health Equity w/Dr. Stephanie Young Moss | Holistic Pharmacy Podcast

Today I want to highlight the work of another pharmacy and entrepreneur colleague, Dr. Stephanie Young Moss (aka “Yomo”). She caught my eye on Instagram, where she shines her light on wellness, family dynamics, pharmacy practice, and disparities in healthcare. A practical tip that she shared in the episode has stuck with me, about how learning goes both ways. For example, shadowing allows healthcare students to learn from professionals, but the mentors also get the opportunity to learn. A relationship with someone different than you helps you understand where they’re coming from and how you can serve different populations.
Dr. Stephanie received her Doctor of Pharmacy degree from Xavier University of Louisiana College of Pharmacy and a Masters of Health Services Administration with a concentration in Health Economics from The University of Wyoming. She has worked in various areas in pharmacy, Community, Regulatory Compliance, Managed Care, and Health Economics and Outcomes Research.
Over the past 20 years Dr. Moss has advocated for decreasing disparities in health care through her volunteer work. She uses her platform to educate families across the U.S. on ways to decrease and eliminate health disparities by incorporating simple wellness and mental health techniques. Dr. Moss has shared her views on international and national podcasts and local television news stations.
Dr. Stephanie is the creator of the website www.drstephanieyomo.com where you will find practical health and wellness tips, ways to reduce healthcare disparities and simple tips for health and wellness professionals to enhance their presence on social media so they can stand out in their niche, build a successful brand and advocate for important causes.
She is also the owner of Integrative Pharmacy Outcomes and Consulting, which focuses on educating underserved communities on ways to reduce and prevent health disparities.
For nearly 2 decades, Dr. Stephanie has served on various boards and volunteer organizations that focus on health equity, decreasing implicit bias, addressing social determinants of health and empowering communities to advocate for their health. She has served on the boards for The Minority Health Coalition of Marion County and Eskenazi Health Center where she has served as the Clinical Quality Committee Chair, Board Secretary and is currently the Board Treasurer. She resides in Indianapolis, Indiana.
You can connect with Dr. Yomo on all social media (@Dr. Stephanie Yomo) and www.drstephanieyomo.com.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Finance and the Pharmacy Owner: A Conversation With David George | Pharmacy Insiders

Please join the discussion with David George from Total Dose Pharmacy and First Financial Loan Officer, Drew Hegi from First Financial Bank. 
David George is one of the founders of Total Dose Pharmacy that was established in 2013. He began the startup in Oklahoma and subsequently a second store, Hutton Pharmacy. 
Total Dose aims to be embedded as a healthcare cornerstone of every community in which they are located. They strive to be innovative in the services and products they offer, as well as experts in provision of care and education to patients. Ultimately, their goal is to be the pharmacy franchise where patients want to receive healthcare and people want to work.
Drew Hegi, has been a Loan Officer at FFB since 2012. Drew is also an Independent Pharmacy owner. Drew enjoys coaching buyers through the details of pharmacy ownership. Clear communication helps alleviate concerns, and he understands the necessary skills and tools needed to navigate the process.
Learn more about your ad choices. Visit megaphone.fm/adchoices

RxSummit 2022 Conference Summary | PAIN POD

https://www.rx-summit.com/
Dr. Mark Garofoli was live and in person at the 2022 RxSummit Conference which hosted anyone and everyone affiliated with and touched by our country's Drug Crisis. The "Pain Guy" spoke with many federal and state leaders (including our U.S. Drug Czar Dr. Gupta, our NIDA Director Dr. Volkow, DEA leadership, and so on), along with fellow conference presenters and attendees alike. Many of those conversations were recorded and contained within this dynamic conference summary episode of the Pain Pod!
Learn more about your ad choices. Visit megaphone.fm/adchoices

What’s the Impact of the Pharmacy Benefit Manager Transparency Act of 2022

Senator Chuck Grassley (R-Iowa) and Maria Cantwell (D-Wash.) introduced the Pharmacy Benefit Manager Transparency Act of 2022 on May 24, which would make it illegal for PBMs to engage in “spread pricing.” Spread pricing occurs when PBMs charge health plans and payers more for a prescription drug than what they reimburse to the pharmacy — and then keep the difference. For example, when a pharmacist fills a prescription, a PBM handles the process, informing the pharmacy it will be reimbursed $90. 
The PBM then charges the health insurance plan $100 for processing the same prescription. The spread of $10 is pocketed by the PBMs. Related: New PBM players banking on drug pricing transparency for success The bipartisan legislation would empower the Federal Trade Commission (FTC) to increase drug pricing transparency and hold pharmacy benefit managers (PBMs) accountable for unfair and deceptive practices that drive up the costs of prescription drugs at the expense of consumers. 
It also would prohibit arbitrary clawbacks of payments made to pharmacies and require PBMs to report to the FTC how much money they make through spread pricing and pharmacy fees.
SCPC, CEO, Alan Rosenbloom & Senior Director, Regulatory Policy at APhA, Michael Baxter join Todd Eury with the Pharmacy Podcast Network to discuss the impact of the Pharmacy Benefit Manager Transparency Act of 2022 on the Pharmacy Profession.
Learn more about your ad choices. Visit megaphone.fm/adchoices

“My Dexcom changed my life”: Real world experiences with Dexcom G6 | Real Time Real Talk

In this podcast episode, our host Cher Pastore sat down with Matthew Vogel and Jami Klein – Dexcom employees and Dexcom users. Jami is a nurse and a Certified Diabetes Care and Education Specialist. She has been living with Type 1 diabetes since 1988. Matt is a Senior Director of Marketing, focusing on Strategic Partnerships, working with insulin pump and pen integration companies, as well as Digital Health partners. Matt is also living with Type 1 diabetes. They share their personal experiences living with diabetes, their experiences using Dexcom connected devices, and how RT-CGM has improved their lives!
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.
Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to Dexcom G6 User Guide. For product-related questions, please refer to instructions for use. For complete safety information, go to dexcom.com/safety-information Smart devices are sold separately. For a list of compatible smart device visit Dexcom.com/compatibility
Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Data from collaborator devices and products must be verified by those collaborator devices and products. Users should confirm data and connections with their collaborator devices and products.
The Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older.
 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Finding Your Way - A Conversation with Dr. David Marley, PharmD

Finding Your Way: a Conversation with Dr. David Marley, PharmD
 
PUTT founder Dave Marley's recently released book is an exploration of his own extraordinary life. Listen in on this incredibly honest discussion that twists and turns through business ownership, addiction, pharmacy, family, and one man's journey that navigated it all.
 
Book:
Finding Your Way by Dr. David Marley, PharmD
Learn more about your ad choices. Visit megaphone.fm/adchoices

Breaking Down Silos with Pharmacy Intelligence | The Future of Pharmacy Podcast

In struggling to keep up with everyday demand, health system pharmacies must overcome disparate data systems, inadequate information flow, and incongruous workarounds that significantly reduce inventory accuracy. Find out how pharmacy leaders break down these data silos with advanced analytical tools that provide visibility, insight, and workflow enhancements, leading to inventory optimization and cost reduction.In struggling to keep up with everyday demand, health system pharmacies must overcome disparate data systems, inadequate information flow, and incongruous workarounds that significantly reduce inventory accuracy. Find out how pharmacy leaders break down these data silos with advanced analytical tools that provide visibility, insight, and workflow enhancements, leading to inventory optimization and cost reduction.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Diabetes Self Management and Education for Underserved Populations | Beyond the Sig

On today’s episode, we are joined by Dr. Kristen Archibald who is the Chief Operations Officer and Director of Clinical Services for West Towne Pharmacy and Princeton Drug in Johnson City, TN and is also co-owner of Chinook Pharmacy in Lafayette, CO. Dr. Archibald is passionate about community service, disease state education, and patient advocacy, which are perfectly blended in her current role. In today's episode, we learn about the unique challenges and rewards of leading DSMES classes for underserved populations. 
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Godfather of Functional Pharmacy | Robert Kress, B.S. Pharm

I have known Rob Kress RPh, since 2014 and he was the first pharmacist who was talking about functional pharmacy and the opportunity for pharmacists in functional medicine. Rob, graduated from Temple University School of Pharmacy in Philadelphia PA in 1994. After becoming disenchanted with chemical dominant based medical system, Robert took his passion for nutrition and became board certified in clinical nutrition through the Clinical Nutrition Certification Board, as well as trained as a compounding pharmacist through the Professional Compounding Centers of America.  
During this time, he opened his own compounding and nutritional clinic, which blossomed into a complete anti-aging clinic housing other integrative practitioners. Robert became a Certified Clinical Nutritionist, certified in Quantum Reflex Analysis, a practice of kinesiology, as well as have trained and certified in other modalities such as Reiki and auricular acupuncture, a primal health coach, a licensed yoga instructor, and most recently a certified @movnat instructor.  
Currently, Robert consults with both with patients to enhance their health through lifestyle medicine as well other practitioners to help integrate, promote and implement natural medicine in their practices. Robert also provides regular educational Wellness Workshops and writes regularly on the topic of lifestyle medicine and integrative care.  
Robert believes as pharmacists, we are offered the perfect opportunity to integrate natural medicine into our practices, as its core to the history of pharmacy. Patients are looking for natural solutions for their health, while practitioners are looking towards integrative care to help solve their clients problems and enhance their practices.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Acquisition Roadmap: Letter of Intent & Purchase Agreement | Live Oak Bank

In this episode Greco DeValencia, VP of Pharmacy lending at Live Oak Bank talks with Tom Knapp of Brown & Fortunato about an essential step of the acquisition process: the letter of intent and purchase agreement.
Greco De Valencia
VP- Pharmacy
Direct: 910-375-5921
Mobile: 916-710-6669
Email: greco.devalencia@liveoak.bank
Website: www.liveoakbank.com/pharmacy
Tom A. Knapp
Brown & Fortunato, Shareholder
Direct: (806) 345-6344
Email: tknapp@bf-law.com
Website: www.bf-law.com
Learn more about your ad choices. Visit megaphone.fm/adchoices